Showing results (521-530 of 5,984) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|July 31, 2016
Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDACXiaojun Liu, Yingjun Jiang, Billie Nowak, et al.Molecular Cancer Therapeutics|May 21, 2020
Perhexiline Demonstrates FYN-mediated Antitumor Activity in GlioblastomaShiva Kant, Pravin Kesarwani, Anthony R Guastella, et al.Molecular Cancer Therapeutics|May 21, 2020
Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3Alexander Rau, Wolfgang S Lieb, Oliver Seifert, et al.Molecular Cancer Therapeutics|May 21, 2020
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal MelanomaJessica L F Teh, Timothy J Purwin, Anna Han, et al.Molecular Cancer Therapeutics|May 21, 2020
The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2Laetitia Marzi, Yilun Sun, Shar-Yin N Huang, et al.Molecular Cancer Therapeutics|May 7, 2020
Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic SwitchErik T Goka, Pallavi Chaturvedi, Dayrelis T Mesa Lopez, et al.Molecular Cancer Therapeutics|May 7, 2020
A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple MyelomaMarina Li, Cindy Lin, Hui Deng, et al.Molecular Cancer Therapeutics|May 7, 2020
FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung CancerGopika SenthilKumar, Michael M Fisher, Justin H Skiba, et al.Molecular Cancer Therapeutics|July 25, 2015
Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097Ellen Weisberg, Ensar Halilovic, Vesselina G Cooke, et al.Molecular Cancer Therapeutics|July 22, 2016
Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor GrowthMichele C Smith, Mary M Mader, James A Cook, et al.Pageof 599